Drugs / Cannabichromene
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT07087938 Comparator | Jul 2028 → May 2030 | rheumatoid arthritis | Crystal Lederhos Smith | Suspended | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cannabichromene | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07087938 ↗ |
| Modality | Small molecule | — CHEMBL422704 ↗ |